1. Home
  2. AAPG vs FIZZ Comparison

AAPG vs FIZZ Comparison

Compare AAPG & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • FIZZ
  • Stock Information
  • Founded
  • AAPG 2009
  • FIZZ 1985
  • Country
  • AAPG China
  • FIZZ United States
  • Employees
  • AAPG N/A
  • FIZZ N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • FIZZ Beverages (Production/Distribution)
  • Sector
  • AAPG Health Care
  • FIZZ Consumer Staples
  • Exchange
  • AAPG Nasdaq
  • FIZZ Nasdaq
  • Market Cap
  • AAPG 3.6B
  • FIZZ 3.1B
  • IPO Year
  • AAPG 2025
  • FIZZ 1991
  • Fundamental
  • Price
  • AAPG $33.87
  • FIZZ $33.16
  • Analyst Decision
  • AAPG Strong Buy
  • FIZZ Strong Sell
  • Analyst Count
  • AAPG 3
  • FIZZ 1
  • Target Price
  • AAPG $49.00
  • FIZZ $39.00
  • AVG Volume (30 Days)
  • AAPG 8.0K
  • FIZZ 345.1K
  • Earning Date
  • AAPG 11-19-2025
  • FIZZ 12-04-2025
  • Dividend Yield
  • AAPG N/A
  • FIZZ N/A
  • EPS Growth
  • AAPG N/A
  • FIZZ 0.66
  • EPS
  • AAPG N/A
  • FIZZ 1.98
  • Revenue
  • AAPG $54,524,554.00
  • FIZZ $1,202,396,000.00
  • Revenue This Year
  • AAPG N/A
  • FIZZ $2.80
  • Revenue Next Year
  • AAPG $368.64
  • FIZZ $2.19
  • P/E Ratio
  • AAPG N/A
  • FIZZ $16.74
  • Revenue Growth
  • AAPG N/A
  • FIZZ 0.46
  • 52 Week Low
  • AAPG $16.50
  • FIZZ $32.21
  • 52 Week High
  • AAPG $48.45
  • FIZZ $50.51
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • FIZZ 37.39
  • Support Level
  • AAPG $30.93
  • FIZZ $32.68
  • Resistance Level
  • AAPG $34.31
  • FIZZ $33.83
  • Average True Range (ATR)
  • AAPG 0.81
  • FIZZ 0.96
  • MACD
  • AAPG 0.26
  • FIZZ 0.10
  • Stochastic Oscillator
  • AAPG 85.99
  • FIZZ 34.23

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

Share on Social Networks: